The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 201–300 of 1,000
Biomarkers of an Autoimmune Skin Disease—Psoriasis
Jiang, S., Hinchliffe, T. E., & Wu, T. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.04.002 · Cited by 120
“interleukin (IL)-23/Th17 cell axis plays a crucial role in psoriasis pathogenesis [5].”
BackgroundJin, J., Xie, X., Xiao, Y., Hu, H., Zou, Q., Cheng, X., & Sun, S. (2016) · Nature Immunology · doi:10.1038/ni.3347 · Cited by 119
Behzadi, P., Behzadi, E., & Ranjbar, R. (2016) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.63.2016.1.1 · Cited by 120
Weinstein, J. E., & Pepple, K. L. (2018) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000466 · Cited by 117
“IL-23 has a distinct role in the development of autoimmunity, as in the absence of IL-23, Th17 cells still develop, but they are not pathogenic and perform essential homeostatic functions [10].”
De novo development of proteolytically resistant therapeutic peptides for oral administration
Kong, X., Moriya, J., Carle, V., Pojer, F., Abriata, L. A., Deyle, K. M., & Heinis, C. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0556-3 · Cited by 117
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149783 · Cited by 116
“Notably, multiple clinical trials are currently employing the use of IL17A and IL-17RA antibodies for a variety of diseases [27].”
BackgroundCytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
Venkatesha, S. H., Dudics, S., Acharya, B., & Moudgil, K. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010887 · Cited by 116
“IL-23 exerts pro-inflammatory activity with its ability to expand Th17 cells [6,7], whereas IL-27 acts as an anti-inflammatory cytokine in part via the inhibition of Th17 response [8,9].”
BackgroundResultInfluentialWacleche, V. S., Goulet, J.-P., Gosselin, A., Monteiro, P., Soudeyns, H., Fromentin, R., Jenabian, M.-A., Vartanian, S. M., Deeks, S. G., Chomont, N., et al. (2016) · Retrovirology · doi:10.1186/s12977-016-0293-6 · Cited by 114
“Th17 cells are defined by the production of unique effector cytokines (IL-17A, IL-17F, IL-21, IL-22, IL-26, CCL20) under the transcriptional regulation of multiple lineage-specific transcription factors (IRF4, BATF, STAT3, RORγt) [2, 3].”
BackgroundInfluentialThe Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis
Wacleche, V. S., LANDAY, A. L., Routy, J., & Ancuța, P. (2017) · Viruses · doi:10.3390/v9100303 · Cited by 115
“Furthermore, IL-17A is an inducer of antimicrobial peptides including the β-defensins and lipocalin 2 (LCN2) that prevent infection at mucosal surfaces [4,37].”
BackgroundInfluentialIL-12 and IL-23/Th17 axis in systemic lupus erythematosus
Larosa, M., Zen, M., Gatto, M., Jesús, D., Zanatta, E., Iaccarino, L., Inês, L., & Doria, A. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370218824547 · Cited by 114
Astry, B., Venkatesha, S. H., & Moudgil, K. D. (2015) · Cytokine · doi:10.1016/j.cyto.2014.11.020 · Cited by 115
“Natural Th17 cells are present in the skin and mucosa and they can produce IL-17 in response to IL-1 and IL-23 [9,13].”
BackgroundInfluentialmTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
Chen, F., Cao, A., Yao, S., Evans-Marin, H. L., Liu, H., Wu, W., Carlsen, E. D., Dann, S. M., Soong, L., Sun, J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501541 · Cited by 107
“Despite the proinflammatory role of IL-17 in the pathogenesis of IBD highlighted in previous reports (3, 14), recent studies have also demonstrated a protective role of IL-17 in the maintenance of intestinal homeostasis through induction of intestinal epithelial cell expression of antimicrobial peptide and promoting i…”
BackgroundSystemic lupus erythematosus favors the generation of IL-17 producing double negative T cells
Li, H., Adamopoulos, I. E., Moulton, V. R., Stillman, I. E., Herbert, Z. T., Moon, J. J., Sharabi, A., Krishfield, S., Tsokos, M., & Tsokos, G. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16636-4 · Cited by 112
Post-infectious group A streptococcal autoimmune syndromes and the heart
Martin, W. J., Steer, A. C., Smeesters, P. R., Keeble, J., Inouye, M., Carapetis, J. R., & Wicks, I. P. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.005 · Cited by 112
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival
Majumder, S., Amatya, N., Revu, S., Jawale, C. V., Wu, D., Rittenhouse, N., Menk, A., Kupul, S., Du, F., Raphael, I., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0367-4 · Cited by 102
Self-citationThe Roles of Neutrophils in Cytokine Storms
Chan, L., Karimi, N., Morovati, S., Alizadeh, K., Kakish, J. E., Vanderkamp, S., Fazel, F., Napoleoni, C., Alizadeh, K., Mehrani, Y., et al. (2021) · Viruses · doi:10.3390/v13112318 · Cited by 113
Hall, J. A., Pokrovskii, M., Kroehling, L., Kim, B.-R., Kim, S. Y., Wu, L., Lee, J.-Y., & Littman, D. R. (2022) · Immunity · doi:10.1016/j.immuni.2022.09.013 · Cited by 93
“…transcripts encoding proteins that are prominent cell-intrinsic drivers of autoimmune pathogenesis, including Csf2 (Codarri et al., 2011; El-Behi et al., 2011), Il1r1 (Shouval et al., 2016), and Il23r (Abdollahi et al., 2016; Duerr et al., 2006; Gaffen et al., 2014; Hue et al., 2006) (Figure 3B).”
Cribbs, A. P., Terlecki-Zaniewicz, S., Philpott, M., Baardman, J., Ahern, D., Lindow, M., Obad, S., Oerum, H., Sampey, B. P., Mander, P. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919893117 · Cited by 109
“in maintaining tissue barrier homeostasis (2-5).”
Human inborn errors of immunity underlying superficial or invasive candidiasis
Puel, A. (2020) · Human Genetics · doi:10.1007/s00439-020-02141-7 · Cited by 109
T helper type 17 cells in immune-mediated glomerular disease
Krebs, C. F., Schmidt, T., Riedel, J.-H., & Panzer, U. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.112 · Cited by 109
IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases
Beringer, A., & Miossec, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.008 · Cited by 108
Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
Pastor-Fernández, G., Mariblanca, I. R., & Navarro, M. N. (2020) · Cells · doi:10.3390/cells9092044 · Cited by 109
“In this context, blocking antibodies against IL-23 and IL-17 have been approved for treatment of plaque psoriasis, and they are currently under Phase II/Phase III clinical trials for inflammatory bowel diseases, multiple sclerosis, and rheumatoid arthritis [1].”
BackgroundInfluentialSerum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J.-Y., Hall, J. A., Kroehling, L., Wu, L., Najar, T., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.12.008 · Cited by 95
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Giles, D., Moreno-Fernandez, M., & Divanovic, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531153627 · Cited by 95
“Further, use of IL-17A or IL-17RA specific antibodies (Ixekizumab, Secukinumab and Brodalumab), for treatments of psoriasis, psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis are in the final stages of clinical testing something shown to be as safe and efficacious as the current standard-of-care in…”
BackgroundThe role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
Fu, J., Huang, Y., Bao, T., Liu, C., Liu, X., & Chen, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02446-6 · Cited by 107
“The cytokines, including granulocyte colony-stimulating factor (G-CSF) and IL-6 can promote myeloid-driven innate inflammation [33].”
BackgroundSegmented filamentous bacteria, Th17 inducers and helpers in a hostile world
Schnupf, P., Gaboriau‐Routhiau, V., Sansonetti, P. J., & Cerf–Bensussan, N. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.03.004 · Cited by 108
An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease
Bolton, C., Smillie, C. S., Pandey, S., Elmentaite, R., Wei, G., Argmann, C., Aschenbrenner, D., James, K. R., McGovern, D. P. B., Macchi, M., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.11.014 · Cited by 98
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
Egwuagu, C. E., Yu, C., Sun, L., & Wang, R. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.013 · Cited by 105
“Many innate immune cells including DCs, macrophages, B cells and endothelial cells produce IL-23 and the high affinity IL-23 receptor is expressed on activated T cells and other immune cells including Th17 cells, γδ T cells, natural killer T (NKT) cells and innate lymphoid cells (ILCs) [19].”
BackgroundThe obesity-related pathology and Th17 cells
Endo, Y., Yokote, K., & Nakayama, T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2399-3 · Cited by 105
“STAT3 acts in complex with BATF, IRF4, and the co-activator histone acetyltransferase p300 to promote the expression of the genes encoding RORct and Hif1a, which leads to the lineage specification of Th17 cells [85, 86, 89].”
BackgroundInfluentialChuang, H., & Tan, T. (2019) · Cells · doi:10.3390/cells8111433 · Cited by 105
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
Vecellio, M. L., Hake, V. X., Davidson, C., Carena, M. C., Wordsworth, B. P., & Selmi, C. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596086 · Cited by 105
The role of lymphocytes in the development and treatment of alopecia areata
Guo, H., Cheng, Y., Shapiro, J., & McElwee, K. J. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1085306 · Cited by 104
“IL-23, a cytokine produced by DCs and other APCs, serves as a pivotal factor that drives both the differentiation and inflammatory functions of pathogenic TH17 cells [97].”
BackgroundHIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms
Planas, D., Zhang, Y., Monteiro, P., Goulet, J.-P., Gosselin, A., Grandvaux, N., Hope, T. J., Fassati, A., Routy, J., & Ancuța, P. (2017) · JCI Insight · doi:10.1172/jci.insight.93230 · Cited by 105
“Among GALT-infiltrating CD4+ T cells, Th17 cells play a beneficial role in maintaining epithelial cell integrity at barrier surfaces via the production of effector cytokines under the control of lineage-specific transcription factors (15).”
BackgroundKeratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis
Senra, L., Stalder, R., Martínez, D. Á., Chizzolini, C., Boehncke, W., & Brembilla, N. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.009 · Cited by 103
“The IL-17RA subunit is required for the signaling of several IL-17 isoforms (IL-17A, IL-17C, IL-17F, IL-17E) (Gaffen et al., 2014) and has recently proven to be a valid target to treat psoriasis (Bauer et al., 2015; Papp et al., 2014).”
BackgroundChen, X., Sunkel, B. D., Wang, M., Kang, S., Wang, T., Gnanaprakasam, J. R., Liu, L., Cassel, T., Scott, D. A., Muñoz-Cabello, A. M., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm8161 · Cited by 103
Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells
Kónya, V., Czarnewski, P., Forkel, M., Rao, A., Kokkinou, E., Villablanca, E. J., Almer, S. H., Lindforss, U., Friberg, D., Höög, C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.045 · Cited by 103
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
Li, N., Xu, W., Yuan, Y., Ayithan, N., Imai, Y., Wu, X., Miller, H., Olson, M., Feng, Y., Huang, Y. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01411-1 · Cited by 95
Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review
Wu, M., Dai, C., & Zeng, F. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s420850 · Cited by 103
“Th17 cells differentiated by IL-6, IL-1β, and IL-23 stimulation are mostly involved in chronic inflammatory and autoimmune diseases, and Th17 cells differentiated by TGF-β and IL-6 stimulation are less pathogenic and are mainly involved in maintaining tissue homeostasis and immune defense.(70,71) Most of the Th17 cell…”
BackgroundBabaie, F., Hasankhani, M., Mohammadi, H., Safarzadeh, E., Rezaiemanesh, A., Salimi, R., Baradaran, B., & Babaloo, Z. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.014 · Cited by 101
Subclinical gut inflammation in ankylosing spondylitis
Ciccia, F., Rizzo, A. G., & Triolo, G. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000239 · Cited by 101
“IL-23 mainly acts as a regulator of the maturation of autoreactive T cells producing IL-17 (Th17), and promotes chronic inflammation dominated by IL-17, IL-6, IL-8, and TNF-a, as well as by neutrophils and macrophages [31].”
BackgroundJunB is essential for IL-23-dependent pathogenicity of Th17 cells
Hasan, Z., Koizumi, S.-I., Sasaki, D., Yamada, H., Arakaki, N., Fujihara, Y., Okitsu, S., Shirahata, H., & Ishikawa, H. (2017) · Nature Communications · doi:10.1038/ncomms15628 · Cited by 95
Inflammasome: A Double-Edged Sword in Liver Diseases
Luan, J., & Ju, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02201 · Cited by 100
“This finding is in line with previous studies showing the importance of IL-1β for the differentiation of Th17 cells and antigen-driven T cells (47) (48) (49) .”
ResultSense and Immunity: Context-Dependent Neuro-Immune Interplay
Foster, S. L., Seehus, C. R., Woolf, C. J., & Talbot, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01463 · Cited by 100
Identification of Novel Autoantibodies Associated With Psoriatic Arthritis
Yuan, Y., Qiu, J., Lin, Z., Li, W., Haley, C. T., Mui, U. N., Ning, J., Tyring, S. K., & Wu, T. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40830 · Cited by 99
Th17 Cells in Periodontitis and Its Regulation by A20
Huang, N., Dong, H., Luo, Y., & Shao, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742925 · Cited by 100
Erratum: The IL-23–IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.128 · Cited by 99
The mammalian mycobiome: A complex system in a dynamic relationship with the host
Lai, G. C., Tan, T. G., & Pavelka, N. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1438 · Cited by 98
Immunity to commensal skin fungi promotes psoriasiform skin inflammation
Hurabielle, C., Link, V. M., Bouladoux, N., Han, S.-J., Merrill, E. D., Lightfoot, Y. L., Seto, N., Bleck, C. K. E., Smelkinson, M., Harrison, O. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003022117 · Cited by 97
Prevotella Induces the Production of Th17 Cells in the Colon of Mice
Huang, Y. C., Tang, J., Cai, Z., Zhou, K., Chang, L., Bai, Y., & Ma, Y. (2020) · Journal of Immunology Research · doi:10.1155/2020/9607328 · Cited by 99
Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy
Fang, S., Huang, Y., Zhong, S., Li, Y., Zhang, Y., Li, Y., Sun, J. P., Liu, X., Wang, Y., Zhang, S., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01349 · Cited by 95
“Therefore, we examined those RORgt+CCR6+ IL-17A–producing Th17 cells in GO patients and healthy controls.”
BackgroundInfluentialDainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 96
Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ho, L., Luo, S., & Lai, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.009 · Cited by 94
Lee, P. P. W., & Lau, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00735 · Cited by 94
“Activated Th17 cells produce IL-17 and IL-22, which induce antimicrobial peptide production in epithelial cells, and the recruitment and activation of inflammatory cells, especially neutrophils (131).”
BackgroundInterleukin 17A promotes diabetic kidney injury
Ma, J., Li, Y. J., Chen, X., Kwan, T., Chadban, S. J., & Wu, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-38811-4 · Cited by 93
Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?
Ku, C., Chi, C.-Y., von Bernuth, H., & Döffinger, R. (2020) · Human Genetics · doi:10.1007/s00439-020-02180-0 · Cited by 93
The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease
Korta, A., Kula, J., & Gomułka, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210172 · Cited by 94
“CD4+ T cells that do not express the IL-23 receptor develop into Th17 cells after receiving signals from antigen-presenting cells and cytokines such as IL-6, IL-21, and TGF-β.”
BackgroundInfluentialTargeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE
Rozo, C. T., Chinenov, Y. V., Maharaj, R. K., Gupta, S. K., Leuenberger, L., Kirou, K. A., Bykerk, V. P., Goodman, S. M., Salmon, J. E., & Pernis, A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209850 · Cited by 92
Li, J., Wei, H., Krystek, S. R., Bond, D., Brender, T., Cohen, D., Feiner, J., Hamacher, N. B., Harshman, J., Huang, R. Y. ‐., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03058 · Cited by 91
Prinz, I., Sandrock, I., & Mrowietz, U. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191397 · Cited by 91
Interleukin-15 in autoimmunity
Allard‐Chamard, H., Mishra, H. K., Nandi, M., Mayhue, M., Menéndez, A., Ilangumaran, S., & Ramanathan, S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155258 · Cited by 91
Eyerich, K., Weisenseel, P., Pinter, A., Schäkel, K., Asadullah, K., Wegner, S., Muñoz‐Elías, E. J., Bartz, H., Taut, F., & Reich, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049822 · Cited by 91
Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment
Boehncke, W., & Brembilla, N. C. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8634-3 · Cited by 93
“IL23 maintains IL-17A expression in T cells via STAT3 activation [62].”
BackgroundNeutrophil-derived granule cargoes: paving the way for tumor growth and progression
Rawat, K., Syeda, S., & Shrivastava, A. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09951-1 · Cited by 90
Bechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
Self-citationGuerra, E. S., Lee, C. K., Specht, C. A., Yadav, B., Huang, H., Akalin, A., Huh, J. R., Mueller, C., & Levitz, S. M. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006175 · Cited by 88
“Remarkably, whereas dendritic cells and macrophages are thought to be the primary sources of IL-23 in tissue [45,46]; in our aspergillosis models we found eosinophils were the major cell type in the lungs producing IL-23.”
BackgroundGut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 88
“As mentioned before, commensal bacteria are involved in the differentiation of Th17 cells, which are characterized by their production of IL-17 and play a critical role in inflammation [88].”
BackgroundInterleukin‐17 and ischaemic stroke
Zhang, Q., Liao, Y., Liu, Z., Dai, Y., Li, Y., Li, Y., & Tang, Y. (2020) · Immunology · doi:10.1111/imm.13265 · Cited by 88
Cole, S., Murray, J., Simpson, C., Okoye, R., Tyson, K. L., Griffiths, M., Baeten, D., Shaw, S., & Maroof, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585134 · Cited by 88
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
Matejuk, A., Vandenbark, A. A., & Offner, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.672455 · Cited by 78
“The ability of oligodendrocytes to produce IL-17 can influence autoimmunity since dysregulation of IL-17 has been linked to development of MS (116).”
BackgroundStrle, K., Sulka, K. B., Pianta, A., Crowley, J. T., Arvikar, S. L., Anselmo, A. N., Sadreyev, R. I., & Steere, A. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix002 · Cited by 87
“Exposure to interleukin (IL) 23 plays a critical role in the generation of pathogenic TH17 cells [1, 2].”
BackgroundXue, X., Soroosh, P., Leon-Tabaldo, A. D., Luna-Roman, R., Sablad, M., Rozenkrants, N., Yu, J., Castro, G., Banie, H., Fung‐Leung, W., et al. (2016) · Scientific Reports · doi:10.1038/srep37977 · Cited by 87
Lo, B. C., Shin, S. B., Hernaez, D. C., Refaeli, I., Yu, H. B., Goebeler, V., Cait, A., Mohn, W. W., Vallance, B. A., & McNagny, K. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801308 · Cited by 85
“The IL-23–associated immune pathway, composed of RORgt+ CD4+ Th cells, ILCs, and NKTs, has been implicated in the pathogenesis of several chronic immune disorders including IBD (35).”
BackgroundInfluentialPsoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways
Piaserico, S., Orlando, G., & Messina, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169063 · Cited by 85
“Concomitantly, IL-6 and IL-1β induce VLDL synthesis and lower triglyceride clearance, further contributing to the production of small dense LDL and oxLDL [157].”
BackgroundInfluentialChevillard, C., Nunes, J. P. S., Frade, A. F., Almeida, R. R., Pandey, R. P., Nascimento, M. S., Kalil, J. E., & Cunha‐Neto, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02791 · Cited by 87
“In addition, IL-23 is a key stimulatory cytokine for Th17 and innate “type 17” cells that can respond immediately to pathogenic insults; IL-23 may thus also suppress IFN-γ by promoting IL17RA signaling (69).”
BackgroundMima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 84
MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601551 · Cited by 82
“I n the past decade, IL-17 family members have emerged as drivers of inflammatory and autoimmune conditions, particularly psoriasis (1).”
BackgroundSelf-citationAdvances in the study of IL-17 in neurological diseases and mental disorders
Lu, Y., Zhang, P., Xu, F., Zheng, Y., & Zhao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1284304 · Cited by 82
Beringer, A., Thiam, N. N., Molle, J., Bartosch, B., & Miossec, P. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13140 · Cited by 82
Co‐inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity
Basler, M., Lindström, M., LaStant, J., Bradshaw, J. M., Owens, T. D., Schmidt, C., Maurits, E., Tsu, C. A., Overkleeft, H. S., Kirk, C. J., et al. (2018) · EMBO Reports · doi:10.15252/embr.201846512 · Cited by 82
“No significant inhibition of IL-6 secretion by The suppression of Th 17 differentiation relies on the co-inhibition of LMP 7 and LMP 2 Th17 cells play a crucial role in the pathogenesis of autoimmunity [27].”
Goepfert, A., Lehmann, S., Blank, J., Kolbinger, F., & Rondeau, J.-M. (2020) · Immunity · doi:10.1016/j.immuni.2020.02.004 · Cited by 75
Developmental options and functional plasticity of innate lymphoid cells
Lim, A. I., Verrier, T., Vosshenrich, C. A. J., & Santo, J. P. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.010 · Cited by 81
Human IL-23 is essential for IFN-γ–dependent immunity to mycobacteria
Philippot, Q., Ogishi, M., Bohlen, J., Puchan, J., Arias, A. A., Nguyen, T., Martín-Fernández, M., Conil, C., Rinchai, D., Momenilandi, M., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abq5204 · Cited by 80
Topchyan, P., Lin, S., & Cui, W. (2023) · Immune Network · doi:10.4110/in.2023.23.e41 · Cited by 82
“BATF cooperatively binds to other transcription factors, which remodel the chromatin landscape to produce changes in chromatin accessibility (144).”
BackgroundFrieder, J., Kivelevitch, D. N., Haugh, I. M., Watson, I., & Menter, A. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.893 · Cited by 80
Enhancing the Promise of Drug Repositioning through Genetics
Pritchard, J.-L. E., O’Mara, T. A., & Glubb, D. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00896 · Cited by 73
“However, IL-17A belongs to an immune axis with IL-23 (Gaffen et al., 2014) and the association of a variant (rs11209032) ∼15 kb downstream of the gene encoding the IL-23 receptor (IL23R) with ankylosing spondylitis (Burton et al., 2007) thus provided a rationale for repositioning secukinumab to treat this additional i…”
BackgroundInfluentialGenetics and Functional Genomics of Spondyloarthritis
Costantino, F., Bréban, M., & Garchon, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02933 · Cited by 80
A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals
Sobota, R. S., Stein, C. M., Kodaman, N., Scheinfeldt, L., Maro, I. I., Wieland‐Alter, W., Igo, R. P., Magohe, A., Malone, L. L., Chervenak, K. A., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.01.015 · Cited by 80
Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling
Zheng, Q., Martin, R. C., Shi, X., Pandit, H., Yu, Y., Liu, X., Guo, W., Tan, M., Bai, O., Meng, X., et al. (2020) · Theranostics · doi:10.7150/thno.45988 · Cited by 73
“Our results agreed with the general concept that Th17 cells could develop from naïve CD4+ T cell precursors via cytokines to initiate cross-talk between liver cells and innate immune cells [53] in NASH, while a lack of FGF21 could accelerate this process.”
ResultAbboud, A., Namas, R. A., Ramadan, M. I., Mi, Q., Almahmoud, K., Abdul-Malak, O. M., Azhar, N., Zaaqoq, A. M., Namas, R. A., Barclay, D. A., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001951 · Cited by 79
“All Rights Reserved. e1080 www.ccmjournal.org November 2016 • Volume 44 • Number 11 pathogenic Th17 cells or other cell types (e.g., ILCs) (19, 20) in the pathophysiology associated with trauma mortality.”
BackgroundInfluentialIL‐23 drives differentiation of peripheral γδ17 T cells from adult bone marrow‐derived precursors
Papotto, P. H., Gonçalves‐Sousa, N., Schmolka, N., Iseppon, A., Mensurado, S., Stockinger, B., Ribot, J. C., & Silva‐Santos, B. (2017) · EMBO Reports · doi:10.15252/embr.201744200 · Cited by 79
“This rein-forces the rational for targeting the IL-23/IL-17 axis in autoimmune diseases, which has already produced remarkable results in psoriasis and shows great potential in multiple sclerosis [52].”
Cai, Y., Xue, F., Qin, H., Chen, X., Liu, N., Fleming, C., Hu, X., Zhang, H., Chen, F., Zheng, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.019 · Cited by 80
“Previous studies have shown that IL-23 signaling is required for Th17 early activation and acquiring pathogenicity (Burkett et al., 2015; Gaffen et al., 2014).”
BackgroundAdvancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update
Karakioulaki, M., Eyerich, K., & Patsatsi, A. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00832-1 · Cited by 78
“IL-23 is an important cytokine in IgE-mediated responses, which promotes and maintains IL-17 activity and therefore eosinophilia [151, 152].”
BackgroundYin and yang of interleukin-17 in host immunity to infection
Das, S., & Khader, S. A. (2017) · F1000Research · doi:10.12688/f1000research.10862.1 · Cited by 78
Are cytokines and chemokines suitable biomarkers for Takayasu arteritis?
Savioli, B., Abdulahad, W. H., Brouwer, E., Kallenberg, C. G. M., & de Souza, A. W. S. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.023 · Cited by 77
Domingues, R. G., & Hepworth, M. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00116 · Cited by 77
“Additionally IL-17A/F act in part to attract myeloid cells to the tissue site, through the induction of chemokines and growth factor expression by epithelial cells (30, 31).”
Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings
Takeuchi, M., Mizuki, N., & Ohno, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640473 · Cited by 78
The role of IL17B-IL17RB signaling pathway in breast cancer
Alinejad, V., Dolati, S., Motallebnezhad, M., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.120 · Cited by 77
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
Ventura, A., Mazzeo, M., Gaziano, R., Galluzzo, M., Bianchi, L., & Campione, E. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s136986 · Cited by 76
“Its neutralization has potential utility in other autoimmune disorders.(79,80) Based on the evidence available, regarding the role of Th17 cells in psoriasis and psoriatic arthritis, three therapeutic agents against IL-17A have been developed: secukinumab, ixekizumab, and brodalumab.”
Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
Chizzolini, C., Dufour, A. M., & Brembilla, N. C. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.09.007 · Cited by 76
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
Self-citation
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.